Focussing on cytotoxic treatment alone is not enough
•
1 like•1,210 views
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com Abstract is available at http://www.pharmaconnectme.com
Report
Share
Report
Share
![European Society of Oncology pharmacy, ESOP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Pharmacy Global Track(s)
The document discusses three principles for European community pharmacy: monopoly on distributing medicine, ownership of pharmacies restricted to pharmacists, and geographical distribution of pharmacies. It then examines how the political, economic, and scientific landscape has changed since these principles were established. Finally, it argues that knowledge and the ability to apply knowledge will be key to addressing modern healthcare challenges in both developing and affluent countries.
Rational drug use
The document discusses rational use of medicines and the role of pharmacists in promoting rational use. It defines rational use of medicines according to WHO as ensuring patients receive appropriate medicines based on their clinical needs at the lowest cost. Pharmacists can promote rational use by properly managing drug stocks, dispensing medications correctly with patient education, and participating in pharmacovigilance programs. The document also outlines several other strategies to improve rational use, including developing treatment guidelines, regulating drug promotion, and educating both healthcare providers and the public.
Pharmaceutical Care of Patients with Infections | 29/03/2010
The document discusses the role of pharmacists in promoting prudent antibiotic use and stewardship. It covers common bacterial infections seen in primary and secondary care, highlighting appropriate first-line antibiotic choices. It also describes current problems with MRSA and C. difficile infections, and the pharmacist's role in managing and preventing the spread of these infections.
Lode Wigersma - Selling Sickness 2010
The document summarizes guidelines for providing information about diseases and prescription medicines to the public in the Netherlands. It outlines the Dutch regulatory system for pharmaceutical advertising and promotion. The guidelines were developed in response to increased disease awareness campaigns and public demand for prescription medicine information. They establish standards for balanced, complete information about diseases and technical information about prescription medicines. The guidelines apply to all parties providing such information and include conditions like not misleading the public or leading to unnecessary medical treatment. A transitional period was provided for adjusting existing information to the new guidelines.
PERSONALIZED MEDICINE,CUSTOMIZED DRUG DELIVERY SYSTEM ,3D PRINTING ,TELEPHARM...
Personalized medicine aims to provide the right drug to the right patient at the right time and dose based on their genetic profile. It enables more effective and safer medicines by better matching patients to drugs and eliminating adverse reactions. Developments like 3D printing, telepharmacy, and bioelectronic devices can help deliver customized medicine. Pharmacogenomics and pharmacogenetics study how genetic factors affect individual drug responses and are important to personalized medicine.
Tailor made medicine
This document discusses the emerging field of personalized or tailored medicine. It begins with an introduction to personalized medicine, defining it as tailoring medical treatments to an individual's characteristics. The document then covers the history and driving factors behind personalized medicine. It discusses the goals and benefits of personalized medicine, as well as some limitations. Potential applications discussed include pharmacogenetics, pharmacometabonomics, and cancer management. Several examples of personalized cancer treatments and diagnostics are provided. The document emphasizes that a one-size-fits-all approach to medicine is often ineffective and can cause harm, whereas personalized medicine aims to provide each patient with the right treatment.
Rational use of medicine
Rational use of medicine aims to ensure patients receive appropriate medications based on their needs. Irrational use can occur when there is polypharmacy, unnecessary or incorrect medications, underuse of effective medicines, or unsafe drug use. This presentation identifies factors contributing to irrational use at the international, national, health systems, prescriber, dispensing, and patient levels. These include issues like drug promotion, regulations, infrastructure, education and adherence. Strategies to improve rational use involve educational programs for prescribers and patients, management techniques, economic approaches, and regulatory policies like essential drug lists and multi-disciplinary oversight bodies.
Quality use medicine
Quality Use of Medicines means:
• Selecting management options wisely by:
Considering the place of medicines in treating illness and maintaining health, and
recognising that there may be better ways than medicine to manage many disorders.
• Choosing suitable medicines if a medicine is considered necessary so that the best available option is selected by taking into account:
- the individual
- the clinical condition
- risks and benefits
- dosage and length of treatment
- any co-existing conditions
- other therapies
- monitoring considerations
- costs for the individual, the community and the health system as a whole.
Recommended
Pharmacy Global Track(s)
The document discusses three principles for European community pharmacy: monopoly on distributing medicine, ownership of pharmacies restricted to pharmacists, and geographical distribution of pharmacies. It then examines how the political, economic, and scientific landscape has changed since these principles were established. Finally, it argues that knowledge and the ability to apply knowledge will be key to addressing modern healthcare challenges in both developing and affluent countries.
Rational drug use
The document discusses rational use of medicines and the role of pharmacists in promoting rational use. It defines rational use of medicines according to WHO as ensuring patients receive appropriate medicines based on their clinical needs at the lowest cost. Pharmacists can promote rational use by properly managing drug stocks, dispensing medications correctly with patient education, and participating in pharmacovigilance programs. The document also outlines several other strategies to improve rational use, including developing treatment guidelines, regulating drug promotion, and educating both healthcare providers and the public.
Pharmaceutical Care of Patients with Infections | 29/03/2010
The document discusses the role of pharmacists in promoting prudent antibiotic use and stewardship. It covers common bacterial infections seen in primary and secondary care, highlighting appropriate first-line antibiotic choices. It also describes current problems with MRSA and C. difficile infections, and the pharmacist's role in managing and preventing the spread of these infections.
Lode Wigersma - Selling Sickness 2010
The document summarizes guidelines for providing information about diseases and prescription medicines to the public in the Netherlands. It outlines the Dutch regulatory system for pharmaceutical advertising and promotion. The guidelines were developed in response to increased disease awareness campaigns and public demand for prescription medicine information. They establish standards for balanced, complete information about diseases and technical information about prescription medicines. The guidelines apply to all parties providing such information and include conditions like not misleading the public or leading to unnecessary medical treatment. A transitional period was provided for adjusting existing information to the new guidelines.
PERSONALIZED MEDICINE,CUSTOMIZED DRUG DELIVERY SYSTEM ,3D PRINTING ,TELEPHARM...
Personalized medicine aims to provide the right drug to the right patient at the right time and dose based on their genetic profile. It enables more effective and safer medicines by better matching patients to drugs and eliminating adverse reactions. Developments like 3D printing, telepharmacy, and bioelectronic devices can help deliver customized medicine. Pharmacogenomics and pharmacogenetics study how genetic factors affect individual drug responses and are important to personalized medicine.
Tailor made medicine
This document discusses the emerging field of personalized or tailored medicine. It begins with an introduction to personalized medicine, defining it as tailoring medical treatments to an individual's characteristics. The document then covers the history and driving factors behind personalized medicine. It discusses the goals and benefits of personalized medicine, as well as some limitations. Potential applications discussed include pharmacogenetics, pharmacometabonomics, and cancer management. Several examples of personalized cancer treatments and diagnostics are provided. The document emphasizes that a one-size-fits-all approach to medicine is often ineffective and can cause harm, whereas personalized medicine aims to provide each patient with the right treatment.
Rational use of medicine
Rational use of medicine aims to ensure patients receive appropriate medications based on their needs. Irrational use can occur when there is polypharmacy, unnecessary or incorrect medications, underuse of effective medicines, or unsafe drug use. This presentation identifies factors contributing to irrational use at the international, national, health systems, prescriber, dispensing, and patient levels. These include issues like drug promotion, regulations, infrastructure, education and adherence. Strategies to improve rational use involve educational programs for prescribers and patients, management techniques, economic approaches, and regulatory policies like essential drug lists and multi-disciplinary oversight bodies.
Quality use medicine
Quality Use of Medicines means:
• Selecting management options wisely by:
Considering the place of medicines in treating illness and maintaining health, and
recognising that there may be better ways than medicine to manage many disorders.
• Choosing suitable medicines if a medicine is considered necessary so that the best available option is selected by taking into account:
- the individual
- the clinical condition
- risks and benefits
- dosage and length of treatment
- any co-existing conditions
- other therapies
- monitoring considerations
- costs for the individual, the community and the health system as a whole.
Promoting Rational drugs in NRHM
This document discusses promoting rational drug use in India under the National Rural Health Mission. It begins by outlining the objectives and defining the problem of irrational drug use in India. Some key points made include that India accounts for 22% of the global disease burden but only produces 2% of global drugs. It then discusses the reasons for irrational drug use, including factors related to patients, prescribers, drug regulation, and the drug supply system. Strategies presented to promote rational drug use include ensuring availability of essential drugs, access and affordability, and rational prescriptions. The challenges of implementation are also acknowledged.
Clinical pharmacist Managed Oncology Clinic In University Hospital
The document discusses the role and history of clinical pharmacists in managing oncology clinics. It describes how clinical pharmacists began in the 1960s and their role has expanded over the years. The main goals of clinical pharmacists are to assist physicians in prescribing and monitoring drug therapy, assist medical staff, and maximize patient compliance. Oncology pharmacists play a vital role on the healthcare team by ensuring optimal medication regimens for cancer patients, educating patients, and monitoring patients for side effects during chemotherapy treatment.
Tbsrud3nov09
This document summarizes a presentation on promoting rational use of medicines. It discusses:
1) The definition of rational drug use and the magnitude of irrational use globally. Interventions like standard treatment guidelines and educational strategies are discussed.
2) Data on inadequate diagnosis and overuse of injections in developing countries is presented.
3) Strategies to promote rational use include educational, managerial, economic and regulatory approaches. Educational strategies target both providers and consumers. Managerial strategies include essential drug lists and supervision. Economic strategies aim to remove financial incentives for irrational prescribing.
4) Studies evaluating the impact of various interventions like training, supervision, guidelines and public policies generally find a significant positive effect on rational drug use outcomes. Multi-
The Future of pharmacogenomics applications in Alberta Community Pharmacies
The document discusses current efforts in Alberta, Canada to implement pharmacogenomic (PGx) testing in community pharmacies. A few pharmacies started offering PGx testing services in 2016. A 2018 study found that while patients are open to PGx testing, pharmacists lack confidence in counseling on genetic results and PGx education is needed in pharmacy curricula. Alberta regulatory and educational organizations are working to increase PGx implementation and awareness among pharmacists and patients. A 2020-2021 study will expand PGx services to rural areas and assess clinical outcomes to support wider adoption across Alberta pharmacies.
Quality Use of Medicines
The document discusses Quality Use of Medicines (QUM), which aims to ensure optimal health outcomes from medication use. QUM focuses on selecting management options wisely, choosing suitable medicines appropriately, and using medicines safely and effectively. The National Medicines Policy also aims to ensure timely access to medicines, quality products, quality use, and a viable medicines industry. Key partners in achieving QUM include healthcare providers and recipients, as well as governments, industry, and educators.
Clinical pharmacy– a key role
This document provides an introduction to clinical pharmacy presented by Ian and Judith Coombes to students in Sri Lanka. In 3 sentences:
The presentation discusses the role of clinical pharmacy in improving patient care by identifying and resolving medication-related issues, outlines differences between healthcare systems in Australia and Sri Lanka, and emphasizes the need for pharmacists to adopt a patient-centered approach through effective communication and consultation to optimize drug therapy and prevent adverse events.
Detection, reporting and management of adverse events
This document discusses adverse drug reactions (ADRs), including definitions, classifications, detection, reporting, and management. It notes that ADRs are a major clinical problem that can cause suffering and increased healthcare costs. It emphasizes the importance of monitoring and reporting ADRs to improve patient safety. Pharmacists can play an important role by monitoring high-risk patients and drugs, educating on ADR reporting, and assisting in the detection and assessment of ADRs. Timely reporting of ADRs is crucial to help prevent human suffering and unnecessary costs from drug-related injuries.
Prescription event monitoring
The document describes Prescription Event Monitoring (PEM), a method of pharmacovigilance that involves collecting information on patient outcomes after being prescribed new medications. PEM was developed in the 1980s in the UK to address limitations of spontaneous adverse event reporting. It involves sending questionnaires to prescribers to obtain follow-up data on patients. Analysis of the data provides incidence rates of adverse events and allows detection of potential safety issues with new drugs. Modified PEM (M-PEM) expands the method to collect additional targeted safety information.
Essential drug for B. Sc. Nursing 1st year students of BPKIHS
Essential drug for B. Sc. Nursing 1st year students of BPKIHSBP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
This document provides guidelines for physicians, pharmacists, nurses and medical auxiliaries on essential drugs. It includes an introduction by the Director of the World Health Organization's Essential Drugs and Other Medicines department, as well as sections on the editorial committee, contributors, preface, foreword, and use of the guide.Essential medicine concepts
The document discusses the concept of essential medicines. It begins by defining essential medicines as those that satisfy the priority health care needs of the majority of the population and should be available at all times in adequate amounts and affordable price. It then outlines the history of the WHO Model List of Essential Medicines, criteria for selecting essential medicines, guidelines for establishing national essential medicines programs, and advantages and disadvantages of essential medicines lists. It also summarizes recommendations from the 18th WHO Model List and 4th Essential Medicines List for Children from 2013.
Introduction Clinical Pharmacy Practices
Introduction to Clinical Pharmacy Practice, Definitions and Aim, Objectives, Scopes or services of Clinical Pharmacy, Functions and Roles of Clinical Pharmacy, Qualities of Clinical Pharmacy.
Introduction to rational use of drugs and role of pharmacist in rational use...
This document discusses strategies for promoting rational use of drugs in healthcare systems. It recommends establishing a national drug regulatory authority to oversee drug quality, developing treatment guidelines and an essential drug list. Healthcare professionals should be provided drug information and undergo continuing education on rational prescribing. Generic names should be used and drugs prescribed according to their intended therapeutic uses and appropriate dosages. Quality of drugs must be ensured and irrational self-medication discouraged through public education. Monitoring drug use through indicators can help evaluate prescribing practices and promote rational drug utilization.
Oncology Treatment Guidelines : The Rules and Rationale
This document discusses clinical practice guidelines for oncology treatment. It defines what guidelines are and their purpose in helping clinicians make complex treatment decisions. Guidelines should be based on systematic reviews of evidence, developed by multidisciplinary experts, and provide recommendations along with ratings of evidence quality. The document notes limitations of guidelines and the need for them to be relevant to the local healthcare system and population. It advocates for guidelines developed through a transparent process with management of conflicts of interest.
Personalized Medicine: Uptake Challenges
Most healthcare systems across Europe are not set up to jointly assess personalised medicines and their companion diagnostics in a holistic way. This can lead to lower reimbursement prices and slower uptake of these novel drugs. There are three main challenges: 1) current systems focus on organs and diseases rather than biological pathways, 2) payers and policymakers are skeptical of claims of increased pricing and unfamiliar evidence, and 3) systems consider drugs and diagnostics separately rather than together. To address this, companies must understand countries' assessment approaches and generate evidence to demonstrate the value of jointly assessing personalized treatments and diagnostics.
Essential medicine
The document discusses the history and development of essential medicines. It outlines key events like the growth of new drugs post-WWII, the thalidomide tragedy of 1960, and the 1978 Alma-Ata declaration which established primary health care and inclusion of essential drugs. The WHO defines essential medicines as those that satisfy the majority of a population's health needs. Selection criteria include disease patterns, treatment facilities, and financial resources. National drug policies aim to ensure appropriate access to and use of essential medicines.
Essential drug concept and rational use of medicines
This document discusses the essential medicine concept and rational use of medicines. It defines essential medicines as those that meet the health needs of a population based on effectiveness, safety, and cost. Essential medicine lists include generic drug names, dosage forms, strengths, and indications. Irrational medicine use can lead to ineffective or unsafe treatment, increased costs and resistance. Rational use means using medicines appropriately for each patient's needs in terms of drug choice, dosage, duration, and cost. The document outlines various educational, managerial, regulatory and economic strategies to promote rational medicine use.
Essential drug list
The document discusses the concept of essential medicines and rational use of drugs. It defines essential medicines as those that meet the priority health care needs of the population. The WHO publishes a Model List of Essential Medicines every two years to guide countries in developing their own national lists. Educational, managerial, economic and regulatory strategies can be used to promote rational drug use and selection of cost-effective treatments. Pharmacists can play a role through drug selection, inventory control, patient education, and pharmaceutical care.
Personalized Medicine – From Theory to Practice
Personalized Medicine – From Theory to Practice as presented by keynote speaker Ralph Snyderman, MD; Director of the Center for Research on Prospective Health Care, James B. Duke Professor of Medicine, Chancellor Emeritus, Duke University
Concept of essential drugs and rational use of drugs
It is an essential part of Clinical Pharmacy topic and belongs from the Hospital & clinical pharmacy subject
Concept of essential medicines and rational use of medicines
This document discusses essential medicines and rational drug use. It defines essential medicines as those that meet the priority health care needs of the population based on efficacy, safety and cost-effectiveness. The WHO publishes a model list of essential medicines that is divided into core and complementary items. Rational drug use means using the appropriate medicine at the right dose for the correct duration. Promoting rational use involves training, continuing education, and formulary guidance. Irrational use increases costs and harms patients.
Ppt for staff training on biomedical waste mgmt
This document discusses biomedical waste management. It defines biomedical waste as waste generated from medical facilities that can be hazardous to humans and the environment. The rules for handling biomedical waste in India are outlined, which require proper sorting, storage, transport, treatment and disposal of wastes. Biomedical waste must be categorized and disposed of appropriately to avoid health risks like infections, injuries, and transmission of diseases. The document emphasizes the need for waste management plans in medical facilities to safely dispose of biomedical waste.
immuno pcr
This document provides an overview of Immuno-Polymerase chain reaction (Immuno-PCR or IPCR). Immuno-PCR combines antigen-antibody binding with PCR amplification to detect antigens. It was developed in 1992 by Sano, Smith, and Cantor. Immuno-PCR attaches a marker DNA molecule to an antigen-antibody complex, then amplifies the attached DNA via PCR. This provides ultrasensitive detection, with 10-1000 times greater sensitivity than ELISA. Key steps involve immobilizing antibodies, adding the sample, adding a second antibody coupled to DNA, amplifying the DNA, and detecting the amplified DNA product. Benefits include improved sensitivity for detecting low antigen quantities and applications in disease diagnosis
More Related Content
What's hot
Promoting Rational drugs in NRHM
This document discusses promoting rational drug use in India under the National Rural Health Mission. It begins by outlining the objectives and defining the problem of irrational drug use in India. Some key points made include that India accounts for 22% of the global disease burden but only produces 2% of global drugs. It then discusses the reasons for irrational drug use, including factors related to patients, prescribers, drug regulation, and the drug supply system. Strategies presented to promote rational drug use include ensuring availability of essential drugs, access and affordability, and rational prescriptions. The challenges of implementation are also acknowledged.
Clinical pharmacist Managed Oncology Clinic In University Hospital
The document discusses the role and history of clinical pharmacists in managing oncology clinics. It describes how clinical pharmacists began in the 1960s and their role has expanded over the years. The main goals of clinical pharmacists are to assist physicians in prescribing and monitoring drug therapy, assist medical staff, and maximize patient compliance. Oncology pharmacists play a vital role on the healthcare team by ensuring optimal medication regimens for cancer patients, educating patients, and monitoring patients for side effects during chemotherapy treatment.
Tbsrud3nov09
This document summarizes a presentation on promoting rational use of medicines. It discusses:
1) The definition of rational drug use and the magnitude of irrational use globally. Interventions like standard treatment guidelines and educational strategies are discussed.
2) Data on inadequate diagnosis and overuse of injections in developing countries is presented.
3) Strategies to promote rational use include educational, managerial, economic and regulatory approaches. Educational strategies target both providers and consumers. Managerial strategies include essential drug lists and supervision. Economic strategies aim to remove financial incentives for irrational prescribing.
4) Studies evaluating the impact of various interventions like training, supervision, guidelines and public policies generally find a significant positive effect on rational drug use outcomes. Multi-
The Future of pharmacogenomics applications in Alberta Community Pharmacies
The document discusses current efforts in Alberta, Canada to implement pharmacogenomic (PGx) testing in community pharmacies. A few pharmacies started offering PGx testing services in 2016. A 2018 study found that while patients are open to PGx testing, pharmacists lack confidence in counseling on genetic results and PGx education is needed in pharmacy curricula. Alberta regulatory and educational organizations are working to increase PGx implementation and awareness among pharmacists and patients. A 2020-2021 study will expand PGx services to rural areas and assess clinical outcomes to support wider adoption across Alberta pharmacies.
Quality Use of Medicines
The document discusses Quality Use of Medicines (QUM), which aims to ensure optimal health outcomes from medication use. QUM focuses on selecting management options wisely, choosing suitable medicines appropriately, and using medicines safely and effectively. The National Medicines Policy also aims to ensure timely access to medicines, quality products, quality use, and a viable medicines industry. Key partners in achieving QUM include healthcare providers and recipients, as well as governments, industry, and educators.
Clinical pharmacy– a key role
This document provides an introduction to clinical pharmacy presented by Ian and Judith Coombes to students in Sri Lanka. In 3 sentences:
The presentation discusses the role of clinical pharmacy in improving patient care by identifying and resolving medication-related issues, outlines differences between healthcare systems in Australia and Sri Lanka, and emphasizes the need for pharmacists to adopt a patient-centered approach through effective communication and consultation to optimize drug therapy and prevent adverse events.
Detection, reporting and management of adverse events
This document discusses adverse drug reactions (ADRs), including definitions, classifications, detection, reporting, and management. It notes that ADRs are a major clinical problem that can cause suffering and increased healthcare costs. It emphasizes the importance of monitoring and reporting ADRs to improve patient safety. Pharmacists can play an important role by monitoring high-risk patients and drugs, educating on ADR reporting, and assisting in the detection and assessment of ADRs. Timely reporting of ADRs is crucial to help prevent human suffering and unnecessary costs from drug-related injuries.
Prescription event monitoring
The document describes Prescription Event Monitoring (PEM), a method of pharmacovigilance that involves collecting information on patient outcomes after being prescribed new medications. PEM was developed in the 1980s in the UK to address limitations of spontaneous adverse event reporting. It involves sending questionnaires to prescribers to obtain follow-up data on patients. Analysis of the data provides incidence rates of adverse events and allows detection of potential safety issues with new drugs. Modified PEM (M-PEM) expands the method to collect additional targeted safety information.
Essential drug for B. Sc. Nursing 1st year students of BPKIHS
Essential drug for B. Sc. Nursing 1st year students of BPKIHSBP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
This document provides guidelines for physicians, pharmacists, nurses and medical auxiliaries on essential drugs. It includes an introduction by the Director of the World Health Organization's Essential Drugs and Other Medicines department, as well as sections on the editorial committee, contributors, preface, foreword, and use of the guide.Essential medicine concepts
The document discusses the concept of essential medicines. It begins by defining essential medicines as those that satisfy the priority health care needs of the majority of the population and should be available at all times in adequate amounts and affordable price. It then outlines the history of the WHO Model List of Essential Medicines, criteria for selecting essential medicines, guidelines for establishing national essential medicines programs, and advantages and disadvantages of essential medicines lists. It also summarizes recommendations from the 18th WHO Model List and 4th Essential Medicines List for Children from 2013.
Introduction Clinical Pharmacy Practices
Introduction to Clinical Pharmacy Practice, Definitions and Aim, Objectives, Scopes or services of Clinical Pharmacy, Functions and Roles of Clinical Pharmacy, Qualities of Clinical Pharmacy.
Introduction to rational use of drugs and role of pharmacist in rational use...
This document discusses strategies for promoting rational use of drugs in healthcare systems. It recommends establishing a national drug regulatory authority to oversee drug quality, developing treatment guidelines and an essential drug list. Healthcare professionals should be provided drug information and undergo continuing education on rational prescribing. Generic names should be used and drugs prescribed according to their intended therapeutic uses and appropriate dosages. Quality of drugs must be ensured and irrational self-medication discouraged through public education. Monitoring drug use through indicators can help evaluate prescribing practices and promote rational drug utilization.
Oncology Treatment Guidelines : The Rules and Rationale
This document discusses clinical practice guidelines for oncology treatment. It defines what guidelines are and their purpose in helping clinicians make complex treatment decisions. Guidelines should be based on systematic reviews of evidence, developed by multidisciplinary experts, and provide recommendations along with ratings of evidence quality. The document notes limitations of guidelines and the need for them to be relevant to the local healthcare system and population. It advocates for guidelines developed through a transparent process with management of conflicts of interest.
Personalized Medicine: Uptake Challenges
Most healthcare systems across Europe are not set up to jointly assess personalised medicines and their companion diagnostics in a holistic way. This can lead to lower reimbursement prices and slower uptake of these novel drugs. There are three main challenges: 1) current systems focus on organs and diseases rather than biological pathways, 2) payers and policymakers are skeptical of claims of increased pricing and unfamiliar evidence, and 3) systems consider drugs and diagnostics separately rather than together. To address this, companies must understand countries' assessment approaches and generate evidence to demonstrate the value of jointly assessing personalized treatments and diagnostics.
Essential medicine
The document discusses the history and development of essential medicines. It outlines key events like the growth of new drugs post-WWII, the thalidomide tragedy of 1960, and the 1978 Alma-Ata declaration which established primary health care and inclusion of essential drugs. The WHO defines essential medicines as those that satisfy the majority of a population's health needs. Selection criteria include disease patterns, treatment facilities, and financial resources. National drug policies aim to ensure appropriate access to and use of essential medicines.
Essential drug concept and rational use of medicines
This document discusses the essential medicine concept and rational use of medicines. It defines essential medicines as those that meet the health needs of a population based on effectiveness, safety, and cost. Essential medicine lists include generic drug names, dosage forms, strengths, and indications. Irrational medicine use can lead to ineffective or unsafe treatment, increased costs and resistance. Rational use means using medicines appropriately for each patient's needs in terms of drug choice, dosage, duration, and cost. The document outlines various educational, managerial, regulatory and economic strategies to promote rational medicine use.
Essential drug list
The document discusses the concept of essential medicines and rational use of drugs. It defines essential medicines as those that meet the priority health care needs of the population. The WHO publishes a Model List of Essential Medicines every two years to guide countries in developing their own national lists. Educational, managerial, economic and regulatory strategies can be used to promote rational drug use and selection of cost-effective treatments. Pharmacists can play a role through drug selection, inventory control, patient education, and pharmaceutical care.
Personalized Medicine – From Theory to Practice
Personalized Medicine – From Theory to Practice as presented by keynote speaker Ralph Snyderman, MD; Director of the Center for Research on Prospective Health Care, James B. Duke Professor of Medicine, Chancellor Emeritus, Duke University
Concept of essential drugs and rational use of drugs
It is an essential part of Clinical Pharmacy topic and belongs from the Hospital & clinical pharmacy subject
Concept of essential medicines and rational use of medicines
This document discusses essential medicines and rational drug use. It defines essential medicines as those that meet the priority health care needs of the population based on efficacy, safety and cost-effectiveness. The WHO publishes a model list of essential medicines that is divided into core and complementary items. Rational drug use means using the appropriate medicine at the right dose for the correct duration. Promoting rational use involves training, continuing education, and formulary guidance. Irrational use increases costs and harms patients.
What's hot (20)
Clinical pharmacist Managed Oncology Clinic In University Hospital
Clinical pharmacist Managed Oncology Clinic In University Hospital
The Future of pharmacogenomics applications in Alberta Community Pharmacies
The Future of pharmacogenomics applications in Alberta Community Pharmacies
Detection, reporting and management of adverse events
Detection, reporting and management of adverse events
Essential drug for B. Sc. Nursing 1st year students of BPKIHS
Essential drug for B. Sc. Nursing 1st year students of BPKIHS
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...
Oncology Treatment Guidelines : The Rules and Rationale
Oncology Treatment Guidelines : The Rules and Rationale
Essential drug concept and rational use of medicines
Essential drug concept and rational use of medicines
Concept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugs
Concept of essential medicines and rational use of medicines
Concept of essential medicines and rational use of medicines
Viewers also liked
Ppt for staff training on biomedical waste mgmt
This document discusses biomedical waste management. It defines biomedical waste as waste generated from medical facilities that can be hazardous to humans and the environment. The rules for handling biomedical waste in India are outlined, which require proper sorting, storage, transport, treatment and disposal of wastes. Biomedical waste must be categorized and disposed of appropriately to avoid health risks like infections, injuries, and transmission of diseases. The document emphasizes the need for waste management plans in medical facilities to safely dispose of biomedical waste.
immuno pcr
This document provides an overview of Immuno-Polymerase chain reaction (Immuno-PCR or IPCR). Immuno-PCR combines antigen-antibody binding with PCR amplification to detect antigens. It was developed in 1992 by Sano, Smith, and Cantor. Immuno-PCR attaches a marker DNA molecule to an antigen-antibody complex, then amplifies the attached DNA via PCR. This provides ultrasensitive detection, with 10-1000 times greater sensitivity than ELISA. Key steps involve immobilizing antibodies, adding the sample, adding a second antibody coupled to DNA, amplifying the DNA, and detecting the amplified DNA product. Benefits include improved sensitivity for detecting low antigen quantities and applications in disease diagnosis
Carcinoma of endometrium
Carcinoma of the endometrium is one of the most common gynecological cancers, especially in postmenopausal white women. There is no effective screening program. Risk factors include estrogen exposure, obesity, and nulliparity. Symptoms include postmenopausal bleeding. Diagnosis involves endometrial biopsy. Treatment depends on staging and includes surgery with radiation or chemotherapy for advanced cases. Prognosis depends on staging, histology, and treatment received.
Tumor immunity
This lecture discusses how the immune system responds to tumors and how tumors evade the immune system. It covers various types of tumor antigens recognized by the immune system, including products of mutated genes, overexpressed proteins, and oncofetal antigens. The immune system mounts cellular and humoral responses against tumors through cytotoxic T cells, NK cells, macrophages, and antibodies. However, tumors have developed mechanisms to evade the immune system, such as antigen loss, lack of costimulation, immunosuppression, and inducing T cell apoptosis. Understanding the immune response and evasion is crucial for developing immunotherapies against cancer.
Immunity. Basic princeples of humoral and cellular immune response.
The document summarizes the basic principles of humoral and cellular immunity. It describes the three lines of defense of the immune system - anatomical, inflammatory, and adaptive. The adaptive immune response involves both humoral immunity mediated by antibodies and B cells, as well as cellular immunity mediated by T cells, macrophages, and natural killer cells. The key steps of antigen processing, presentation to T cells, and activation of both B cells and T cells are outlined. The roles of cytokines, interferons, complement proteins, and memory cells in the immune response are also summarized.
Plegable Biología Molecular
The document discusses research into controlling inflammatory and immune responses through proteins like STAT 3 and GR. It also discusses the potential medical applications of studying the genetics of sea urchins, which share over 7,000 genes with humans. Researchers hope to better understand transcription factors and how genetic expression is regulated in order to develop new treatments for diseases. Studying other species like sea urchins and sponges that can return cells to a stem cell state may also provide insights into how humans can fight diseases through genetic manipulation and therapy.
immuno pcr , immuno;ogy,, ELISA
Immuno-PCR (IPCR) is a highly sensitive method for detecting antigens that combines immunoassay and PCR. It works by attaching a marker DNA molecule to an antigen-antibody complex. A segment of the marker DNA is then amplified via PCR, demonstrating the presence of the antigen. IPCR provides dramatically improved sensitivity over ELISA, allowing detection of highly diluted samples. It also allows for quantification and uses reduced volumes and quantities of reagents while maintaining specificity. IPCR has applications in biological and medical sciences such as diagnoses, microbial detection, and measuring low levels of proteins.
Anticancer drugs 1 introduction and classification
Anticancer drugs work by killing cancer cells or modifying their growth. Most were discovered between 1950-1970 after nitrogen mustard was first used in the 1940s. Cancer treatment includes chemotherapy, radiotherapy, immunotherapy, and surgery. The aims of cancer therapy are to cure or prolong remission, provide palliation, or use adjuvant chemotherapy after surgery/radiotherapy. Anticancer agents are classified as cytotoxic drugs, targeted drugs, or hormonal drugs. Cytotoxic drugs include alkylating agents, platinum agents, antimetabolites, microtubule damaging agents, topoisomerase inhibitors, and antibiotics. They work by various mechanisms such as cross-linking DNA, inhibiting DNA/RNA synthesis, or interfering with microtubule
Humoral immune response
This document provides an overview of the immune response and immune system. It describes the mechanisms of innate immunity including anatomical, physiological, cellular, and inflammatory barriers that provide non-specific protection. Adaptive immunity is induced when innate immunity fails, and has antigen specificity and immunological memory. B and T lymphocytes mediate humoral and cell-mediated immunity respectively. The process of phagocytosis and antibody production are explained. Primary and secondary immune responses differ in lag period, magnitude, and antibody class. Innate and adaptive immunity cooperate to eliminate pathogens.
Viewers also liked (9)
Immunity. Basic princeples of humoral and cellular immune response.
Immunity. Basic princeples of humoral and cellular immune response.
Anticancer drugs 1 introduction and classification
Anticancer drugs 1 introduction and classification
Similar to Focussing on cytotoxic treatment alone is not enough
Oral chemotherapy leadership project -update
The document summarizes recommendations for nurse follow-up of patients on oral chemotherapy at CCH Paynesville, Specialty Services-Oncology. It provides background information on oral chemotherapy and discusses the importance of patient education and monitoring by nurses. The document recommends that nurses follow-up with patients weekly for the first month, every other week for months two and three, and monthly thereafter. It also provides tips on documenting education and monitoring side effects.
Cancer and nursing
This document provides an overview of cancer terminology, statistics, risk factors, causes, diagnostic tests, staging, grading, and common treatments. It discusses who is most likely to get cancer and lists some of the most common cancer types by gender. The document outlines cancer classification systems and explains staging and grading. It details various diagnostic tests and tumor boards. Common treatments discussed include surgery, chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. The document covers side effects of different treatments and ways to mitigate them. It provides examples of common cancers and their typical treatment approaches.
LGS Foundation 2016 Conference - Sunday
This document provides an overview of emerging therapies for Lennox-Gastaut syndrome (LGS) and the clinical trials process. There are currently several FDA-approved treatments for LGS that help reduce seizures, but there remain unmet needs. New treatments are typically medications or devices developed by pharmaceutical companies or academic centers. Clinical trials go through phases to test safety, efficacy, and side effects. Some challenges in trials for LGS include accurately counting and classifying seizure types. Careful patient selection and diagnosis are important. The document reviews examples of clinical trials and considerations for different epilepsy syndromes.
Pregnancy & Addiction 2011 - Revision 2
This document provides an overview of addiction and pregnancy, including:
- Rates of drug and alcohol use during pregnancy range from 12-24% and pose risks to fetal development.
- Treatment includes medication-assisted therapy with methadone or buprenorphine, which can improve outcomes compared to untreated addiction.
- Babies exposed to opioids in utero may develop neonatal abstinence syndrome requiring supportive care and sometimes pharmacological treatment.
Sunitinib for the pancreatic neuroendocrine tumors, Moh'd sharshir
1) Pancreatic neuroendocrine tumors are rare tumors that arise in the pancreas and often spread to the liver. Surgery is the primary treatment but many tumors are inoperable or metastasize.
2) The study examined using the drug sunitinib to treat advanced pancreatic neuroendocrine tumors, as these tumors rely on angiogenesis facilitated by growth factors like VEGF.
3) In a phase 3 clinical trial, 171 patients were randomized to receive either sunitinib or a placebo pill daily. Sunitinib was shown to significantly extend progression-free survival compared to the placebo. Overall survival and response rates were also improved with sunitinib treatment.
CLINICAL PHARMACY.pptx
Clinical pharmacy is a health science discipline in which pharmacists provide patient care that optimizes medication therapy and promotes health, and disease prevention.
Community Pharmacy.
Hospital Pharmacy.
Clinical Pharmacy.
Industrial Pharmacy.
Compounding Pharmacy.
Consulting Pharmacy.
Ambulatory Care pharmacy.
Regulatory Pharmacy.
Prostate cancer case answer
Docetaxel plus prednisone is the standard first-line chemotherapy for metastatic castration-resistant prostate cancer. Cabazitaxel is an option for second-line chemotherapy.
Other options include:
- Abiraterone acetate (CYP17 inhibitor) plus prednisone
- Enzalutamide (second-generation antiandrogen)
- Radium-223 (alpha particle-emitting radiopharmaceutical) for symptomatic bone metastases
- Investigational therapies through clinical trials
Close monitoring of response and side effects is important with any of these advanced therapies. Palliative care should also be incorporated to maximize quality of life.
Non hodgkin lymphoma case answers
This document discusses a case of a patient diagnosed with non-Hodgkin lymphoma (NHL). Key details include:
- The patient has signs and symptoms consistent with NHL such as fever, night sweats, and weight loss. Imaging and labs also confirm NHL.
- The patient's disease stage is determined using an appropriate staging system. Factors like elevated LDH and low albumin affect his prognosis.
- Goals of therapy are to maximize curability while minimizing short and long term complications.
- The recommended treatment regimen is R-CHOP chemotherapy given every 3 weeks for 6 cycles. This includes rituximab, cyclophosphamide, doxorubicin, vincristine,
Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion an...
Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion an...PVI, PeerView Institute for Medical Education
Chair and Presenters, Sumanta Kumar Pal, MD, FASCO, Pedro C. Barata, MD, MSc, FACP, David F. McDermott, MD, and Tian Zhang, MD, MHS, prepared useful Practice Aids pertaining to renal cell carcinoma for this CME/MOC/NCPD/AAPA/IPCE activity titled “Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion and Sequencing Strategies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3uvvd5X. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 25, 2025.Overuse of Stress Ulcer prophylaxis (SUP)
Prevelance of SUP overuse in Alexandria hospitals and determination of factors influencing prescribing behavior among physicians
Lecture 2 2011 1 pharm (student)-1
This document discusses the nurse's responsibilities regarding safe medication administration. Nurses must know the name, use, effects, interactions and monitoring needs of any drugs they administer. They are responsible for ensuring the right patient receives the right drug by the right route at the right time with right documentation. Errors must be reported to improve safety. The nursing process of assessment, diagnosis, planning, implementation and evaluation should be applied to medication administration.
Anesthesia for non Obstetric Surgery in Pregnancy
This document discusses anaesthesia considerations for non-obstetric surgery during pregnancy. It notes that while no anaesthetic agents have been proven to be teratogenic in humans, surgery can increase risks of preterm labour, abortion, or perturbations in uteroplacental blood flow that could impact the fetus. It emphasizes the importance of consulting an obstetrician prior to any invasive procedures or surgery during pregnancy due to their expertise in maternal-fetal physiology. Regional anaesthesia is generally preferred over general anaesthesia when possible.
Presentation1 A
The document discusses principles of pharmacology relevant to nursing care. It covers topics like absorption, distribution, metabolism, and excretion of drugs in the body. It also describes how the nursing process is used to administer medications safely, including assessment of the patient's drug history and monitoring the effects of treatment. Special considerations for neonatal, pediatric, and elderly patients are addressed regarding how their bodies process medications differently.
Breast cancer survivorship
Breast cancer survivors face a variety of potential long-term side effects from their treatment. These include cardiac dysfunction from chemotherapy drugs like anthracyclines and trastuzumab, neuropathy from taxanes, bone loss from aromatase inhibitors and premature menopause, neurocognitive effects from chemotherapy, sexual dysfunction and infertility from hormonal treatments, and risk of secondary malignancies from chemotherapy drugs like anthracyclines. Careful screening and monitoring of survivors can help identify and manage these late effects to improve quality of life. Lifestyle factors like exercise and diet also impact long-term health after breast cancer.
Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Acr...
Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Acr...PVI, PeerView Institute for Medical Education
Chair and Presenters Sumanta Kumar Pal, MD, FASCO, Prof. Laurence Albiges, MD, PhD, and David F. McDermott, MD, prepared useful Practice Aids pertaining to renal cell carcinoma for this CME/MOC/AAPA activity titled “Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Across Treatment Settings.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at https://bit.ly/3LtPuyF. CME/MOC/AAPA credit will be available until December 10, 2024.Nejm journal watch practice changing articles 2014
This document provides a compilation of summaries of the latest practice-changing articles from NEJM Journal Watch. It includes summaries of articles on topics such as delayed or no antibiotic prescriptions for respiratory infections, physical therapy being beneficial for knee osteoarthritis, low-dose steroids being better than high-dose for COPD exacerbations, a diagnostic algorithm for upper-extremity deep vein thrombosis, evidence that meniscal tears may not require surgery, improvements in mental health with smoking cessation, doubts cast on flu drugs by meta-analyses, the 2014 recommended childhood immunization schedule, sentinel lymph node biopsies for thin melanomas, age-specific d-dimer cutoffs for pulmonary embolism, evidence that FOD
CLINICAL PHARMACY.pptx
POINTS TO BE INCLUDED
Definition, scope,
Technical definitions, common terminologies used in clinical
settings
Daily activities of clinical pharmacists
Ward round participation
Treatment Chart Review
Adverse drug reaction monitoring
Interprofessional collaboration
Pancreatic Cancer Advances in Treatment Assignment.pdf
This document provides information on pancreatic cancer, including a description of the disease, risk factors, signs and symptoms, assessment, staging, and treatment options. It summarizes that pancreatic cancer is difficult to diagnose early and has a poor prognosis. Treatment may include surgery, chemotherapy, and radiation therapy depending on the type and stage of cancer. Pain management and palliative care are also important to improve quality of life.
Personalized Therapies for OA: Can Biomarkers Get Us There?
This document discusses the potential for using biomarkers to enable personalized therapies for osteoarthritis (OA). It defines key terms like personalized therapies, biomarkers, phenotypes, and endotypes. The presenter argues that biomarkers could help identify the right treatment for individual OA patients by enabling prognostic and predictive enrichment in clinical trials. However, moving biomarkers from discovery to clinical validation and use involves a long process including assay development, testing biological links and hypotheses, and conducting randomized controlled trials. Several studies are highlighted that have discovered potential new biomarkers and are beginning to test biological links and hypotheses regarding how biomarkers may reflect disease processes and response to treatments.
Cancer Pain Management with Methdaone
This document discusses methadone, an opioid analgesic narcotic used for moderate to severe pain. It is metabolized by the CYP3A4 and CYP-450 enzyme systems and the P-glycoprotein efflux protein. Methadone has the potential for interactions due to its metabolism and should be used cautiously in elderly cancer patients taking multiple medications. The goal for elderly cancer patients is to reduce pain and improve quality of life using appropriate assessment tools and monitoring for side effects and comorbidities.
Similar to Focussing on cytotoxic treatment alone is not enough (20)
Sunitinib for the pancreatic neuroendocrine tumors, Moh'd sharshir
Sunitinib for the pancreatic neuroendocrine tumors, Moh'd sharshir
Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion an...
Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion an...
Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Acr...
Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Acr...
Nejm journal watch practice changing articles 2014
Nejm journal watch practice changing articles 2014
Pancreatic Cancer Advances in Treatment Assignment.pdf
Pancreatic Cancer Advances in Treatment Assignment.pdf
Personalized Therapies for OA: Can Biomarkers Get Us There?
Personalized Therapies for OA: Can Biomarkers Get Us There?
More from inemet
EUFEPS and European Initiatives in Pharmaceutical Sciences
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Legal requirements for generics and abridged products and bioequivalence
This document summarizes key concepts related to legal requirements for generic and abridged drug products, including definitions, regulations, bioequivalence, and pros and cons of generic drugs. It discusses definitions of innovator products, generic medicines, pharmaceutical equivalence and alternatives. It also covers requirements for generic drug applications, marketing authorizations, and the need to demonstrate bioequivalence to the reference product through appropriate studies. Guidelines for bioavailability and bioequivalence studies from regulatory authorities are mentioned.
Significance of BA/BE studies in drug research and evaluation of different as...
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
The role of dissolution in the demonstration of bioequivalence
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Future trends and perspectives in modern pharmaceutical biotechnology
1. The document discusses trends and perspectives in modern pharmaceutical biotechnology, including the development from traditional biotechnology using secondary metabolites to modern biotechnology using recombinant DNA techniques.
2. It describes the transition from first generation biopharmaceuticals that mimic natural proteins to second generation biopharmaceuticals with improved properties through techniques like PEGylation, protein engineering, and protein fusions.
3. The introduction of biosimilars, advances in gene therapy and tissue engineering, and progress toward personalized drug therapy are also discussed as important trends and future perspectives in the field.
Bioavailability and bioequivalence – problems and pitfalls
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Quo Vadis EU Pharmacy?
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Education - Do we have a choice?
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
The truth between the lines – Community pharmacists in improving the health o...
Community pharmacists can play an important role in improving public health by providing evidence-based advice and services. This includes promoting healthy behaviors, preventing disease, identifying health issues, and supporting those with long-term conditions. The evidence shows pharmacists are well-positioned for this work given their accessibility and the frequent contact the public has with pharmacies. However, pharmacists need more support to take a holistic, proactive approach to public health rather than just reacting to issues related to medicines. Priority areas for pharmacists to provide brief lifestyle advice include physical activity, weight management, diet, nutrition, smoking, and alcohol.
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
POSTGENETICS MEDICINE
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Sightseeing Pharmacy practice - The way forward
The document discusses future options for community pharmacy practice and trends influencing those options. It outlines four potential models for future pharmacy practice: a shop model focused on over-the-counter sales; a commercial chain model with limited professional services; a "MacPharmacy" model focused only on fast-moving prescriptions; and a professional practice/clinic model providing complex patient care services in collaboration with other health providers. Each model is described and questions are posed about how each option would impact patients, the profession, and monopoly over pharmacy services. Implementation of new practice models is discussed as requiring change management and addressing barriers through a stepwise project plan.
EU telematics in the regulation of pharmaceuticals
The document discusses EU Telematics, which are IT systems developed at the European level to support the regulation of medicinal products across the European Union and European Economic Area. It describes several key IT systems, including EudraCT for clinical trials, EudraVigilance for monitoring adverse drug events, EudraPharm for product information, and EudraGMP for good manufacturing practice inspections. These systems were created to facilitate information sharing, avoid duplication, and support the regulatory process for medicinal products throughout their lifecycle across multiple countries.
Generics and Biogenerics
The document summarizes trends in research and development of generic drugs in the global pharmaceutical industry. It provides an overview of historical developments in generic drug maker PLIVA dating back to 1928, and its combination with Barr Group in 2006 to form a global generic pharmaceutical company. It also discusses trends in the generic drug market, strategies for differentiation, and key factors for success in generic drug research and development, emphasizing the importance of speed, intellectual property positioning, and internal API development capabilities.
Pharmacovigilance Workshop
The document outlines a pharmacovigilance workshop, including definitions of pharmacovigilance, the need for monitoring drug safety post-approval, and the pharmacovigilance system process of collecting, evaluating and taking action on adverse drug reactions. The workshop introduction discusses educational activities in Croatia to increase healthcare professional reporting of adverse reactions.
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
The document discusses using patient-reported outcome measures like health-related quality of life (HRQoL) to evaluate the benefits of drug therapy from the patient's perspective. While traditionally outcomes were measured clinically, there is a shift towards considering how patients feel treatment impacts their daily lives. The document outlines challenges in defining what constitutes a clinically significant change in HRQoL and proposes further refining measures and educating clinicians on appropriate HRQoL data use.
Making knowledge matter: The Skills Inventory and the Competency Maps
This document discusses the importance of knowledge and skills for economic life. It introduces the concepts of a skills inventory and competency maps for assessing knowledge dimensions and mapping competencies. Various experts are quoted on topics like learning, knowledge, and skill development.
Trigger Point – Self-medication: Patients in white coats
This document summarizes the key points from a presentation on self-medication given at the Pharmacon 2007 European Congress. The presentation covered:
- The structure of the pharmaceutical market and definitions of prescription vs non-prescription medicines
- Results from a study on consumer attitudes towards purchasing self-medication products at pharmacies across Europe
- Areas of cooperation between industry groups representing manufacturers of non-prescription medicines and pharmacist/medical doctor organizations
- The economic and public health value of self-medication
- The future role of pharmacists in supporting self-care and recommendations around pharmacy design, education, and visibility of non-prescription products.
Pharmacy in croatia - A short overview
Croatia has a population of 4.4 million with 978 community pharmacies. The pharmacy network is regulated based on geographic and demographic criteria. Pharmacists must obtain a license through education and training. Continuing education is required to renew licenses every six years. Key challenges include incomplete legislation, delays in medicine reimbursement, and a lack of rural pharmacies.
More from inemet (20)
EUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical Sciences
Legal requirements for generics and abridged products and bioequivalence
Legal requirements for generics and abridged products and bioequivalence
Significance of BA/BE studies in drug research and evaluation of different as...
Significance of BA/BE studies in drug research and evaluation of different as...
The role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalence
Future trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnology
Bioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfalls
The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...
EU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticals
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
Making knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency Maps
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats
Recently uploaded
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
Sensation is the neurological process by which we become aware of surrounding environment.
Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfChulalongkorn Allergy and Clinical Immunology Research Group
Pollen and Fungal allergy
Presented by Chaloemchai Chumsaengchotsakul, MD.
June 14, 2024Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
What are the different types of Dental implants.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Kosmoderma Academy Of Aesthetic Medicine
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
vonoprazan A novel drug for GERD presentation
Vonoprazan, a new potassium acid channel blocker used in the conditions of GERD and gastric ulcer, duodenal ulcer ....
Ageing, the Elderly, Gerontology and Public Health
Challenges associated with ageing from a public health perspective
Recently uploaded (20)
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
Focussing on cytotoxic treatment alone is not enough
- 1. FOCUSSING ON CYTOTOXIC TREAT-MENT ALONE IS NOT ENOUGH Per Hartvig, European Society of Oncology Pharmacy, ESOP and University hospital pharmacy, Uppsala, Sweden
- 24. Fatigue and other side effects